Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Aceragen Inc reported $17.86M in Current Assets for its fiscal quarter ending in December of 2022.

Current Assets Change
Abbott ABT:US USD 24.38B 847M
Aceragen Inc IDRA:US USD 17.86M 12.21M
Agenus AGEN:US USD 205.69M 7.43M
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Amgen AMGN:US USD 44.7B 22.52B
Biogen BIIB:US USD 9.76B 28.7M
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
Dynavax Technologies DVAX:US USD 830.14M 86.84M
Eli Lilly LLY:US USD 20.81B 2.78B
Gilead Sciences GILD:US USD 14.37B 855M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Mirati Therapeutics MRTX:US USD 939.35M 169.61M
Nektar Therapeutics NKTR:US USD 491.07M 54.9M
Roche Holding ROG:VX CHF 33.82B 3.5B
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Seattle Genetics SGEN:US USD 2.6B 200.62M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M